文献速递眼底病与葡萄膜炎小儿眼科与斜弱视

在日本队列中回顾性验证早产后生长发育与早产儿视网膜病变(G-ROP)标准

Retrospective Validation of the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Criteria in a Japanese Cohort.
PubMed 文献 · Am J Ophthalmol · 2019-04-04

本研究在日本单中心对2009年9月至2017年5月筛查的692名早产儿中537名有ROP结局和体重增长数据者,外部验证G-ROP标准(除外脑积水标准)预测需治疗ROP的性能,敏感性100%(95%CI 95.4%-100%),特异性28.9%(95%CI 24.9%-33.2%),需筛查婴儿数和检查次数分别减少24.5%和12.9%。

要点

  • G-ROP标准在日本队列中预测需治疗ROP的敏感性为100%(95%CI 95.4%-100%)。
  • 特异性为28.9%(95%CI 24.9%-33.2%),需筛查婴儿数和检查次数分别减少24.5%和12.9%。
  • 风险判定日期前无婴儿需要ROP治疗,该标准在除外脑积水标准后仍具高敏感性。

核心结论

  • 这是G-ROP标准在北美以外发达国家的首个验证研究,该标准在日本队列中表现出高敏感性,即使排除了脑积水标准。

研究设计与样本

  • 在日本单中心回顾性审查2009年9月至2017年5月筛查ROP的早产儿,对692名中537名有ROP结局和连续体重增长测量者应用G-ROP标准(除外脑积水)进行验证。

主要发现

  • 537名婴儿中81名需ROP治疗,218名ROP自行消退,238名未发生ROP。
  • G-ROP模型预测需治疗ROP的敏感性为100%(95%CI 95.4%-100%),特异性为28.9%(95%CI 24.9%-33.2%)。
  • 风险判定日期前无婴儿需要ROP治疗。
  • 需筛查婴儿数减少24.5%,检查次数减少12.9%。

关键数值与推荐

  • G-ROP标准(除外脑积水)预测需治疗ROP的敏感性100%(95%CI 95.4%-100%),特异性28.9%(95%CI 24.9%-33.2%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We aimed to externally validate the performance of new screening criteria for retinopathy of prematurity (ROP) developed in the Postnatal Growth and Retinopathy of Prematurity (G-ROP) study among a Japanese cohort. DESIGN: Validation of screening criteria. METHODS: We reviewed premature infants screened for ROP between September 2009 and May 2017 at a single institution. The G-ROP criteria, except hydrocephalus, were applied as a prediction model for infants with both a known outcome of ROP and serial measurements of weight gain. We assessed sensitivity and specificity for treatment-requiring ROP, and reduction in the number of infants who receive ROP screening and in the number of retinal examinations. RESULTS: Of 692 premature infants screened for ROP, 537 had information of ROP outcome and weight gain. In this cohort, 81 infants required treatment for ROP; in 218 infants, ROP regressed spontaneously; and 238 infants did not develop any ROP. The G-ROP model reached a sensitivity of 100% (95% confidence interval [CI], 95.4%-100%) and specificity of 28.9% (95% CI, 24.9%-33.2%). No infants required any treatment for ROP before the date of risk determination. The number of infants requiring screening and the number of examinations would have been reduced by 24.5% and 12.9%, respectively. CONCLUSIONS: This is the first validation study of the G-ROP criteria in a developed country other than North America. The criteria demonstrated high sensitivity in this Japanese cohort, even though the criterion of hydrocephalus was excluded.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Shiraki A, Fukushima Y, Kawasaki R, et al. Retrospective Validation of the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Criteria in a Japanese Cohort. Am J Ophthalmol. 2019. PMID: 30954468. doi:10.1016/j.ajo.2019.03.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。